Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22

References

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three dimensional structure of foot and mouth disease virus at 2.9Å resolution. Nature, London 327:709–716
   [Google Scholar]
2. Arrowsmith A. E. M. 1975; Variation among strains of type A foot- and-mouth disease virus in the Eastern Mediterranean region 1964–1972. Journal of Hygiene 75:387–97
   [Google Scholar]
3. Bahnemann H. G. 1973; The inactivation of FMDV by ethyleneimine and propyleneimine. Zentralblatt fur Veterinaermedizin Reihe B 20:356–360
   [Google Scholar]
4. Baxt B., Becker Y. 1990; The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot and mouth disease virus to tissue culture cells. Virus Genes 4:73–80
   [Google Scholar]
5. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
   [Google Scholar]
6. Black L., Pullen L., Boge A. 1985; Guinea pig protection test as indicator of potency of oil emulsion foot and mouth disease vaccines. Research in Veterinary Science 39:207–211
   [Google Scholar]
7. Bolwell C., Brown A. L., Barnett P. V., Campbell R. O., Clarke B. E., Parry N. R., Ouldridge E. J., Brown F., Rowlands D. J. 1989a; Host cell selection of antigenic variants of foot-and-mouth disease virus. Journal of General Virology 70:45–57
   [Google Scholar]
8. Bolwell C., Clarke B. E., Parry N. R., Ouldridge E. J., Brown F., Rowlands D. J. 1989b; Epitope mapping of foot and mouth disease virus with neutralizing monoclonal antibodies. Journal of General Virology 70:59–68
   [Google Scholar]
9. Brown F., Cartwright B. 1963; Purification of radioactive foot- and-mouth disease virus. Nature, London 199:1168–1170
   [Google Scholar]
10. Capstick P. B., Garland A. J., Masters R. C., Chapman W. G. 1966; Some functional and morphological alterations occurring during and after the adaptation of BHK 21 clone 13 cells to suspension culture. Experimental Cell Research 44:119–128
    [Google Scholar]
11. Cox D. R. 1989 Analysis of Binary Data Edited by Cox D. R., Snell E. J. London: Chapman and Hall;
    [Google Scholar]
12. Fox G., Parry N. R., Barnett P. V., McGinn B., Rowlands D. J., Brown F. 1989; The cell attachment site on foot and mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Journal of General Virology 70:625–637
    [Google Scholar]
13. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
14. Parry N., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., Stuart D. 1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot and mouth disease virus. Nature, London 347:569–572
    [Google Scholar]
15. Pay T. W. F., Hingley P. J. 1986; The use of serum neutralization antibody assay for the determination of the potency of foot and mouth disease vaccines in cattle. Developments in Biological Standardization 64:153–161
    [Google Scholar]
16. Rweyemamu M. M., Booth J. C., Head M., Pay T. W. F. 1978; Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. Journal of Hygiene 81:107–123
    [Google Scholar]
17. Rweyemamu M. M., Ouldridge E. J., Head M., Purse F. 1984; Evaluation of the antigenic variation within type A foot-and-mouth disease virus isolates from Asia. Journal of Biological Standardization 12:191–194
    [Google Scholar]
18. Surovoi A. Y., Ivanov V. T., Chepurkin A. V., Ivanyushchenkov V. N., Dryagalin N. N. 1989; Is the Arg-Gly-Asp sequence the binding site of foot and mouth disease virus with the cell receptor?. Soviet Journal of Bio-Organic Chemistry 14:572–580
    [Google Scholar]
19. Thomas A. A. M., Woortmeijer R. K., Puijk W., Barteling S. J. 1988; Antigenic sites on foot and mouth disease virus type A10. Journal of Virology 62:2782–2789
    [Google Scholar]
20. Williams D. A. 1986; Interval estimation of the median lethal dose. Biometrics 42:641–645
    [Google Scholar]